A Canadian, Multi-centre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Pediatric Subjects Using SAIZEN® Via Easypod™ Auto-injector for Growth Hormone Treatment
Clinical trial NCT01267526 · COMPLETED
Trial details
- NCT number
- NCT01267526
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-05-31
- Primary completion
- 2015-12-31
- Enrollment
- 205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.